 Expression blood-group antigen favorable prognostic factor non-small-cell lung cancer BACKGROUND New prognostic factors treatment patients non-small-cell lung cancer prognostic value altered expression ABH blood-group antigens multistep process carcinogenesis tumor progression METHODS presence blood-group antigens paraffin-embedded tumor samples patients curative surgery non-small-cell lung cancer Monoclonal antibodies antigens Ulex agglutinin antigen RESULTS Survival patients blood type AB primary tumors negative blood-group antigen patients antigen A-positive tumors patients blood type respective median survival times months Disease patients tumors negative blood-group antigen antigen A-positive patients Expression blood-group antigen tumor cells survival Cox proportional-hazards regression analysis expression blood-group antigen tumor cells prediction overall survival prognostic factors patients blood type AB CONCLUSIONS Expression blood-group antigen tumor cells important favorable prognostic factor patients non-small-cell lung cancer variable design future trials therapy